Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs BAFNA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES BAFNA PHARMA DIVIS LABORATORIES/
BAFNA PHARMA
 
P/E (TTM) x 87.0 466.1 18.7% View Chart
P/BV x 11.8 2.3 502.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 DIVIS LABORATORIES   BAFNA PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-24
BAFNA PHARMA
Mar-24
DIVIS LABORATORIES/
BAFNA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,072126 3,243.6%   
Low Rs2,82577 3,692.7%   
Sales per share (Unadj.) Rs295.564.4 458.6%  
Earnings per share (Unadj.) Rs60.33.1 1,940.7%  
Cash flow per share (Unadj.) Rs74.55.2 1,428.3%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs511.234.2 1,496.2%  
Shares outstanding (eoy) m265.4723.66 1,122.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.71.6 744.5%   
Avg P/E ratio x57.232.5 175.9%  
P/CF ratio (eoy) x46.319.4 239.1%  
Price / Book Value ratio x6.73.0 228.2%  
Dividend payout %49.80-   
Avg Mkt Cap Rs m915,5082,390 38,307.7%   
No. of employees `000NANA-   
Total wages/salary Rs m10,940190 5,749.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m78,4501,525 5,145.4%  
Other income Rs m3,39035 9,625.2%   
Total revenues Rs m81,8401,560 5,246.6%   
Gross profit Rs m22,060111 19,854.2%  
Depreciation Rs m3,78050 7,567.6%   
Interest Rs m4023 174.7%   
Profit before tax Rs m21,63073 29,436.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6300-   
Profit after tax Rs m16,00073 21,774.6%  
Gross profit margin %28.17.3 385.9%  
Effective tax rate %26.00-   
Net profit margin %20.44.8 423.2%  
BALANCE SHEET DATA
Current assets Rs m101,520945 10,746.3%   
Current liabilities Rs m17,550541 3,245.0%   
Net working cap to sales %107.026.5 404.1%  
Current ratio x5.81.7 331.2%  
Inventory Days Days122 709.1%  
Debtors Days Days101,087 0.9%  
Net fixed assets Rs m57,850532 10,871.6%   
Share capital Rs m530237 224.0%   
"Free" reserves Rs m135,180572 23,639.9%   
Net worth Rs m135,710808 16,787.7%   
Long term debt Rs m0108 0.0%   
Total assets Rs m159,3701,477 10,791.4%  
Interest coverage x541.84.2 12,872.0%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.51.0 47.7%   
Return on assets %10.16.5 154.2%  
Return on equity %11.89.1 129.7%  
Return on capital %16.010.5 151.7%  
Exports to sales %85.20-   
Imports to sales %24.00-   
Exports (fob) Rs m66,870NA-   
Imports (cif) Rs m18,810NA-   
Fx inflow Rs m66,8700-   
Fx outflow Rs m19,1600-   
Net fx Rs m47,7100-   
CASH FLOW
From Operations Rs m12,61095 13,294.7%  
From Investments Rs m-2,690-151 1,786.9%  
From Financial Activity Rs m-7,990-8 94,556.2%  
Net Cashflow Rs m1,930-64 -3,009.0%  

Share Holding

Indian Promoters % 51.9 88.3 58.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 38.3 0.0 -  
FIIs % 17.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 11.7 411.2%  
Shareholders   278,899 7,295 3,823.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs BAFNA PHARM.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs BAFNA PHARM. Share Price Performance

Period Divis Laboratories BAFNA PHARM. S&P BSE HEALTHCARE
1-Day 0.70% -0.04% 0.65%
1-Month 3.39% 1.68% -0.82%
1-Year 62.56% -8.10% 42.79%
3-Year CAGR 8.74% -14.14% 20.12%
5-Year CAGR 28.26% 72.42% 26.10%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the BAFNA PHARM. share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of BAFNA PHARM. the stake stands at 88.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of BAFNA PHARM..

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 49.8%.

BAFNA PHARM. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of BAFNA PHARM..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.